BioCentury
ARTICLE | Clinical News

Ampion: Phase III started

April 8, 2013 7:00 AM UTC

Ampio began a 2-part, double-blind, placebo-controlled Phase III trial of Ampion. The first run-in portion will compare 4 and 10 mL injections of Ampion in 320 patients and will determine the optimal ...